Get the app
public
ios_share
OncoPharm
chevron_right
Breakwater, Ensartinib, & SC Nivo
Jan 9, 2025
10:52
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
We discuss recent approvals of ensartinib and nivolumab-hyaluronidase as well as new front-line option for BRAV-V600E mutated metastatic colorectal cancer.
